Lähettäjä: Soijuv Lähetetty: 10.5.2004 11:40
Doksi aiheuttaa useille maha-suolistokanavan ongelmia ja valoherkkyyttä. Nyt on kehitteillä iholle levitettävä antibiootti.
We are working with transdermal doxycycline and a number of other antibiotics to decrease gut/GI side effects. Already working with doxy, which is cheap, and it seems 200 mg/1 ml equals 200 mg oral since first pass equals the moderate penetration. Only done side if the cream lasts 2 weeks. It can be mixed by competant others in 2 week intervals if clear powder and cream amounts set up.
Further options in early exploration: adding photosensitivity reducers and later have very high doses of doxy (and perhaps another antibiotic which are given IM or IV. Will keep posted.
James
JL Schaller, MD, MAR
Naples, Florida
www.personalconsult.com
UUSI DOKSISYKLIINI KEHITTEILLÄ
Valvojat: Jatta1001, Borrelioosiyhdistys, Bb